UniQure reports RSU vesting and option sale

UniQure N.V. submitted a Form 144 notice reporting proposed dispositions of Ordinary Shares tied to equity compensation.

Rhea-AI Filing Summary

UniQure N.V. submitted a Form 144 notice reporting proposed dispositions of Ordinary Shares tied to equity compensation. The filing lists 7,970 Ordinary Shares from restricted stock unit vesting on 06/11/2026 and 10,000 Ordinary Shares from a stock option exercise and sale pursuant to a 10b5-1 plan on 06/15/2026. The filing indicates the exercise-sale on 06/15/2026 was for cash and that the restricted stock units vesting on 06/11/2026 were issued for services rendered.

Insights

Equity Compensation Counsel

Form 144 lists routine post-vesting and plan-based sales tied to equity compensation.

These entries show a restricted stock unit vesting event for 7,970 shares on 06/11/2026 and a same-month option exercise-and-sale of 10,000 shares executed under a 10b5-1 plan on 06/15/2026. The filing records the economic treatment as services rendered for the RSUs and cash consideration for the exercise-sale.

Timing and method indicate compliance-oriented disclosures rather than strategic market commentary; subsequent filings (if any) will show final broker reports and actual settlement details.

Key Figures

RSU vesting shares: 7,970 shares Option exercise-and-sale: 10,000 shares Transaction consideration: Cash

3 metrics

RSU vesting shares 7,970 shares vested on <date>06/11/2026</date> for services rendered

Option exercise-and-sale 10,000 shares exercise and sale pursuant to a 10b5-1 plan on <date>06/15/2026</date>

Transaction consideration Cash listed for the 10,000-share exercise-sale on <date>06/15/2026</date>

Key Terms

Restricted stock unit vesting, 10b5-1 plan, Form 144, Stock option exercise and sale

4 terms

Restricted stock unit vesting financial

"Restricted stock unit vesting | UniQure N.A. | 7970 | 06/11/2026"

10b5-1 plan regulatory

"Stock option exercise and sale Pursuant to 10b5-1 plan | UniQure N.A."

A 10b5-1 plan is a pre-arranged strategy that allows company insiders to buy or sell their shares at predetermined times and prices, even while they are aware of confidential information. It acts like a scheduled appointment for trading, helping ensure transactions happen transparently and legally, which can reassure investors that trades are not based on insider knowledge.

Form 144 regulatory

"Filer Information | Issuer Information | Securities Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock option exercise and sale financial

"Stock option exercise and sale Pursuant to 10b5-1 plan | 10000 | 06/15/2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does UniQure's (QURE) Form 144 report show?

The Form 144 reports proposed dispositions of equity compensation: 7,970 shares from RSU vesting on 06/11/2026 and 10,000 shares from an option exercise-and-sale on 06/15/2026 under a 10b5-1 plan.

Were the UniQure shares sold as part of a planned program?

Yes. The filing indicates the 10,000-share stock option exercise and sale on 06/15/2026 occurred pursuant to a 10b5-1 plan, which is a pre-arranged trading plan permitting scheduled transactions.

What payment type is listed for the 10,000-share transaction in QURE's Form 144?

The Form 144 shows the stock option exercise-and-sale on 06/15/2026 listed with cash as the consideration, indicating the disposition generated cash proceeds to the selling holder.

What caused the 7,970 UniQure shares to be reportable on Form 144?

The 7,970 shares are reported as the result of restricted stock unit vesting on 06/11/2026, with the filing noting the RSUs were issued for services rendered, creating a reportable disposition.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/11/2026 - 04:29 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001555508
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	uniQure N.V.
SEC File Number	001-36294
Address of Issuer	PAASHEUVELWEG 25A AMSTERDAM NETHERLANDS 1105 BP
Phone	1-339-970-7000
Name of Person for Whose Account the Securities are To Be Sold	Balachandran Madhavan
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Citigroup Global Markets, Inc 390 Greenwich Street New York NY 10013	11993	324577.59	63067485	06/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	06/11/2026	Restricted stock unit vesting	UniQure N.A.			7970	06/11/2026	Services Rendered
Ordinary Shares	06/15/2026	Stock option exercise and sale Pursuant to 10b5-1 plan	UniQure N.A.			10000	06/15/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Shares being sold are pursuant to the vesting and settlement of equity awards. Stock options being exercised and sold pursuant to a 10B5-1 Plan adopted March 16, 26.
Date of Notice	06/11/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/16/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Conformed Signature On File
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)